All In MedTech

FDA Clearance Tracker · P120009-S004

NIT-OCCLUD PDA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 17, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P120009-S004
Device name
NIT-OCCLUD PDA
Applicant location
Carlsbad, CA
Received
Jan 12, 2023
Decided
Oct 17, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P120009

Device type

Device class
Class III

Every decision under product code MAE

FDA's approval statement

As written in FDA's record.

Approval for modifications to the Instructions for Use to reflect the findings of the final Post-Approval Study (PAS) Report submitted for the Nit-Occlud PDA PAS Study

Source documents

Other decisions for Pfm Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

6 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.